Deep exploration of sotorasib-related hepatobiliary AEs: Based on FDA Adverse Event reporting system

Lung Cancer 2026 Open access

Read full text

Authors: Xinmei Pan, Lin Zhang, Linli Xie, Xiaohong Li, Ying Li, Qian Wang, Jing Hu

DOI: 10.1016/j.lungcan.2026.109311

Cited by: 0

References: 35

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Drug-Induced Hepatotoxicity and Protection Drug-Induced Ocular Toxicity

References 35